John Hunter
Chief Tech/Sci/R&D Officer at FIBROGEN, INC.
Profile
John Hunter is currently the Chief Scientific Officer at FibroGen, Inc. He previously worked as a Senior Director at XOMA Corp., Chief Scientific Officer at Compugen Ltd., Vice President-Antibody R&D at Compugen, Inc. (United States), and Chief Executive & Scientific Officer at Keyhole Therapeutics, Inc. Dr. Hunter received his undergraduate degree from Hartwick College and his doctorate from The University of California, San Francisco.
John Hunter active positions
| Companies | Position | Start |
|---|---|---|
| FIBROGEN, INC. | Chief Tech/Sci/R&D Officer | 2021-07-11 |
Former positions of John Hunter
| Companies | Position | End |
|---|---|---|
| XOMA CORPORATION | Director/Board Member | - |
| COMPUGEN LTD. | Chief Tech/Sci/R&D Officer | - |
| Keyhole Therapeutics, Inc. | Chief Executive Officer | - |
| Compugen, Inc. (United States) | Corporate Officer/Principal | - |
Training of John Hunter
| Hartwick College | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| XOMA CORPORATION | Health Technology |
| COMPUGEN LTD. | Health Technology |
| FIBROGEN, INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Compugen, Inc. (United States) | |
| Keyhole Therapeutics, Inc. |
- Stock Market
- Insiders
- John Hunter